Objective: Neonates were monitored with a cerebral oximeter before, during, and after cannulation for ECMO to determine the direct effects of ligation of the right internal jugular vein and right carotid artery on cerebral oxygenation.
Introduction
Several studies in the past showed that cerebral oxygenation can be compromised during surgery to prepare the neonatal patient for extracorporeal membrane oxygenation (ECMO) therapy from noninvasive near infrared spectroscopy (NIRS) techniques, now commonly called cerebral oximetry. [1] [2] [3] [4] During this time, the carotid artery and/or the internal jugular vein are ligated to allow for ECMO support, but the procedure may temporarily impair cerebral perfusion. However, the data collected from the cerebral oximetry monitors used in these past studies were not validated and/or provided only trending cerebral oxygenation information.
The purpose of this study was to monitor physiologic changes in cerebral perfusion using the FORE-SIGHT cerebral oximeter (CAS Medical Systems, Branford, CT) a recently validated and FDA approved monitor, 5 before, during and after cannulation for ECMO. In doing this, we hoped to identify any transient decrease in cerebral saturations with the ligation of the carotid artery and/or the internal jugular vein. As the number of subjects studied in the earlier studies [1] [2] [3] [4] was small, our data will further verify or refute the past findings. In addition, we hoped to show improvement in cerebral oxygenation with the commencement of ECMO.
Extracorporeal membrane oxygenation background
Extracorporeal membrane oxygenation involves using a membrane oxygenator attached to a heart-lung bypass machine to provide cardiopulmonary support to patients who have already failed conventional medical therapies. This type of support is offered in the neonatal intensive care unit to the newborns that have a reversible cause for pulmonary and/or cardiac failure. There are two types of ECMO bypass, veno-arterial (VA) and veno-venous (VV). In VA bypass, deoxygenated blood is removed through a cannula placed in the right internal jugular vein and oxygenated blood is returned to the aortic arch through a cannula placed in the carotid artery. Use of this technique allows the ECMO pump to take over approximately 60% of the function of both the heart and the lungs. If a patient has isolated pulmonary disease and does not require additional cardiac support, he/she would be a candidate for VV-ECMO. In this case, a double lumen catheter is placed in the right atrium through the right internal jugular vein and blood is both removed and replaced in the right atrium. This allows the ECMO membrane oxygenator to provide the needed pulmonary support without sacrificing the carotid artery. In addition, VV-ECMO maintains the normal pulsatility to the systemic flow.
In addition to the double lumen catheter placed in the internal jugular vein toward the heart, patients on VV-ECMO have a second catheter placed in a cephalad direction in the jugular vein. This catheter augments cerebral venous outflow and allows access to blood draining from the cerebral circulation to measure cerebral oxygen saturations. It was through the use of this catheter that Rais-Bahrami et al. 5 were able to validate the FORE-SIGHT cerebral oximeter.
Cerebral oximetry background
The FORE-SIGHT cerebral oximeter measures cerebral tissue oxygen saturation (SctO 2 ) as an absolute value, which does not require a baseline measurement like trending cerebral oximeters. 6 Because the blood in the cerebral microvasculature is a mix of arterioles, venuoles and capillaries, the FORE-SIGHT monitor uses an algorithm that approximates the contribution of venous blood to arterial blood of 70 to 30% ratio. 5, 7, 8 This leads SctO 2 measurements to be less that pulse oximetry measurements (pulse oximeter arterial oxygen saturation (SpO 2 )), less than arterial oxygen saturation (SaO 2 ), but higher than brain venous oxygen saturation SjvO 2 (cephalad catheter internal jugular oxygen saturation; i.e., blood measured from a cephalad catheter of a VV-ECMO patient) by approximately 10%. 5, 6 Besides the obvious benefit of noninvasive, direct measurement of cerebral oxygenation, cerebral oximetry also offers the benefit of working even in cases of nonpulsatile flow. Pulse oximetry requires pulsatile flow to determine oxygen saturation, and therefore does not work in instances where this is compromised, such as in the case of circulatory arrest or cardiopulmonary bypass. The cerebral oximeter can continue to be used in these cases and will display a continuous measurement of cerebral tissue oxygen saturation.
Methods
This study was approved by the Institutional Review Board at Children's National Medical Center. After obtaining parental informed consent, patients that were being placed on either VA or VV-ECMO were enrolled in the study. Before right carotid/internal jugular vein cannulation, the FORE-SIGHT Cerebral Oximeter neonatal size sensor (light source to detector separation of 25 mm) was affixed to the neonate's right forehead using a custom-made adhesive pad and was further secured with Hypafix tape (BSN Medical GmbH & Co. Hamburg, Germany). A laptop computer displayed and stored data every 3 s from the cerebral oximeter along with pulse oximetry SpO 2 data (N395, Tyco/Nellcor, Plesanton, CA USA). Significant event markers were documented for analysis including the start time of surgery, the time of ligation of the jugular vein, the time of ligation of the carotid artery (if patient was going on VA ECMO), the time that the patient was placed on bypass, 30 and 60 min, and 6 h after the onset of ECMO. The data were then analyzed by multiple category repeated measures nonparametric testing (Friedman two-way analysis of variance by SPSS software) to determine significant changes in SctO 2 between events.
Low cerebral desaturation is defined by SctO 2 <60%, which would approximate brain venous or jugular bulb saturation SjvO 2 <50% based on the estimation that SctO 2 is 10% higher than SjvO 2 . 6 A review of the literature revealed that a SjvO 2 <44 to 55% exposed the patient to increased risk of complications, with most institutions recommending keeping SjvO 2 >50%.
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Results Data were successfully collected for 17 ECMO neonatal subjects (13 VA/4 VV) during the surgical period. Demographic information: 7 male/10 female, 7 Caucasian/5 African American/3 Hispanic/2 unspecified, gestation age 38 to 41 weeks, and weight 2.3 to 4.4 kg. Diagnosis included left or right congenital diaphragmatic hernia, primary pulmonary hypertension, sepsis, hypertrophic cardiomyopathy and/or meconium aspiration syndrome. Figure 1 is a box plot showing the SctO 2 median, 25th/75th percentiles, maximum/minimum range, and outlier data points for the 17 subjects for Pre-ECMO events (Pre-Surgery, Surgery Start, common carotid artery (CCA) Ligation, Internal Jugular Vein (IJV) Ligation, and Pre-ECMO (i.e., 2 min before ECMO onset), and ECMO events (ECMO þ 30 min, ECMO þ 60 min and ECMO þ 6 h). Median SctO 2 data from each event consists of 17 data points except CCA ligation, which consists of 13 data points because CCA ligation is not performed for VV ECMO subjects. The three outlier points are from two subjects (see Figures 4 and 5) , who experienced very low SctO 2 values, and needed cardiopulmonary between presurgery and surgery start to Pre-ECMO were statistically significant (P<0.001). The increase of SctO 2 from presurgery, surgery start and Pre-ECMO to ECMO ( þ 30and þ 60 min, and þ 6 h after start) were statistically significant (P<0.01). The increase of SctO 2 from ECMO þ 30 min to ECMO þ 60 min and ECMO þ 6 h were statistically significant (P<0.05). Table 1 shows the time duration in minutes (mean ± s.d.) that SctO 2 was below 40, 50 and 60%, along with range and the number of subjects experiencing SctO 2 below these thresholds for Pre-ECMO surgery and ECMO for 48 h. It was found that during the period of time between IJV Ligation and pre-ECMO onset, most subjects (14/ 17) experienced the lowest SctO 2 values. During this apparent vulnerable period, the minimum mean SctO 2 was 49.2 ± 17.3% (range: 5 to 71%). From Table 1 , SctO 2 events are less frequent once the subject is on ECMO. During ECMO, drops of SctO 2 below 60% were transitory, with SctO 2 recovering rapidly.
The pulse oximeter occasionally failed to measure SpO 2 (three subjects) or was not reflective of cerebral desaturations (one subject) during ECMO surgery. The time in minutes when the pulse oximeter was deemed not reliable or not reflective of cerebral oxygenation was 10 to 29 min for the four subjects. Figure 2 shows an example of a SctO 2 event that was undetected by pulse oximetry. Here, SctO 2 dropped to 44%, whereas SpO 2 remained near 100% at the onset of ECMO. Figure 3 shows multiple desaturation events during Pre-ECMO surgery, where SctO 2 and SpO 2 track each other. Figure 4 shows a CPR case. Here, at the start of cerebral oximetry monitoring, the subject was being sustained by CPR during pre-ECMO surgery with an SctO 2 of 36%. Pulse oximetry was intermittent during this time, likely because of low pulsatile perfusion to the extremities. Once ECMO was started, SctO 2 increased to 60% and normal pulse oximetry function returned. Figure 5 shows another CPR case where very low Figure 2 This representative result shows that occasionally pulse oximetry SpO 2 is insensitive to cerebral oxygen desaturation as indicated by SctO 2 for a neonate undergoing surgery for VV-ECMO (note the decrease of SctO 2 before and during the onset of ECMO, a common observation). ECMO, extracorporeal membrane oxygenation; SctO 2 , cerebral tissue oxygen saturation; SpO 2 , pulse oximeter arterial oxygen saturation. SctO 2 values (5%) were recorded. Pulse oximetry did not function during this period. Once ECMO was started, SctO 2 increased dramatically to over 90% (hyperemia), then settled to 70 to 80%, and normal pulse oximetry function returned.
Discussion
These results show that neonates undergoing ECMO can be exposed to SctO 2 events during pre-ECMO surgery, especially between arterial and jugular venous cannulation to the onset of ECMO. Earlier studies using NIRS to monitor ECMO subjects also observed cerebral oxygenation decreases during ECMO surgery. [1] [2] [3] [4] Ejike et al. 1 reported that only the right cerebral hemisphere experienced SctO 2 following right carotid cannulation in three subjects using a bilateral sensor NIRS system. In our study, the cerebral oximetry sensor was placed on the right forehead. We did not use a left forehead sensor. On the other hand, Van Heijst et al. 4 observed bilateral decrease in cerebral oxygenation following right carotid cannulation in 10 subjects. Procedural differences in technique may explain these findings. Both Ejike et al. 1 and Van Heijst et al. 4 observed a decrease of cerebral oxygenation primarily due to right carotid cannulation but not right internal jugular vein cannulation. 3, 4 Because carotid and internal jugular cannulation were performed about the same time, we did not distinctly see that SctO 2 's were primarily caused by carotid cannulation.
One possible explanation of the observation of decreased cerebral oxygenation following cannulation includes restricted circulatory flow caused by the cannulae. Venous return would be reduced leading to decreased stroke volume and cerebral blood flow. Once the ECMO pump is active, full flow is restored, and cerebral oximetry SctO 2 and pulse oximetry SpO 2 increases. If the cannulae do restrict flow, then initiating ECMO as soon as possible after cannulation may prevent possible prolonged SctO 2 's. 1 Positioning of the neonate during ECMO surgery is another possibility resulting in reduced cerebral blood flow and oxygen desaturation events. Repositioning the neonate after cannulation to restore cerebral blood flow to maintain SctO 2 >60% is a possible solution. Other possibilities causing impaired cerebral oxygenation during ECMO surgery include arterial hypoxia, hypotension, pH and PCO 2 disturbances. All of these perturbations are possible and even common during cannulation surgery.
In some cases, cerebral desaturations may be unavoidable especially for emergency ECMO surgery. These neonates may be undergoing CPR to maintain cerebral perfusion as best as possible. Here, cerebral oximetry can be a tool to determine the effectiveness of CPR, especially when pulse oximetry fails because of the requirement of pulsatile flow to calculate an SpO 2 value. Cerebral oximetry does not need pulsatile flow to determine SctO 2 ; therefore, cerebral oximetry can be used reliably during nonpulsatile flow situations, such as cardiopulmonary bypass, deep hypothermia circulatory arrest, high blood loss/shock, CPR and regional lowflow cerebral perfusion. 5, 6, [17] [18] [19] Our results show that SctO 2 events occur more frequently before starting ECMO compared to after the onset of ECMO. Although ECMO has its known potential risks, we observed that cerebral oxygenation increases during ECMO, and the frequency of SctO 2 events dramatically decreases (assuming normal ECMO pump operation). Once ECMO was established, mean SctO 2 increased during the first 6 h of ECMO. With the exception of one CPR subject, we did not observe a large transient increase of SctO 2 indicative of hyperemia during the start of ECMO, as opposed to the results of Ejike et al.
1 Hyperemia may occur due to changes in ABP, pressor requirements and serum Hb, which are common in this period. Abrupt correction of hypotension and hypoxia cause transient hyperemia in animal models. During ECMO, SctO 2 was Figure 4 During this case, the neonate was sustained by cardiopulmonary resuscitation during surgery for VA ECMO. This case shows that cerebral oximetry SctO 2 is not disturbed by low pulsatile perfusion, as opposed to the intermittent pulse oximetry SpO 2 . SctO 2 recovered to 60% when ECMO was started. ECMO, extracorporeal membrane oxygenation; SctO 2 , cerebral tissue oxygen saturation; SpO 2 , pulse oximeter arterial oxygen saturation; VA, veno-arterial. Figure 5 Another case where the neonate was sustained by cardiopulmonary resuscitation during surgery for VV-ECMO. SctO 2 dropped very low to 5%, then recovered after ECMO start, exhibiting a hyperemic response before settling to 70 to 80%. Pulse oximetry was nonfunctional until the start of ECMO. ECMO, extracorporeal membrane oxygenation; VA, veno-arterial.
consistently above the 60% threshold for all subjects with less variability compared to pre-ECMO. In the past, our institution's goal is to maintain a cephalad SjvO 2 >60% for VV-ECMO cases, which would translate to maintaining cerebral oximetry SctO 2 >70%. For VA-ECMO, no cephalad catheter is used, so maintaining a SctO 2 >70% is our only available guideline. Therefore, cerebral oximetry is the only oximeter useful to maintain safe cerebral oxygenation levels for VA-ECMO subjects. Many VA-ECMO circuits use an in-line mixed venous oxygen saturation monitor that can be useful in estimating cerebral oxygenation status. However, these monitors do not directly monitor the brain-like cerebral oximetry.
Although we define SctO 2 >60% to be a safe level based on the best available information in the literature on brain/jugular bulb venous oxygen saturation SjvO 2 , we do not know the safe upper limit of SctO 2 during ECMO. It is possible that ECMO pump flow could result in excessive flow to the brain. In recent years, cerebral oximetry has begun to move from the research lab into clinical settings. However, routine use of the cerebral oximeter has been hampered by concerns of unreliability and inaccuracy. The FORE-SIGHT Cerebral Oximeter has been shown to be both a valid and reliable tool to be used in the clinical setting. However, there is a paucity of information on how to use the monitor in the clinic most effectively. The clinician's ability to interpret this monitor at the bedside is not as straight forward as previous modalities such as the pulse oximeter. With the pulse oximeter, the expected range for a healthy subject is 90 to 100%. When the patient is outside of this, the bedside physician knows how to respond. With the cerebral oximeter, there is a wide range for what is considered to be 'normal' cerebral oxygenation. SctO 2 values are expected to be below SaO 2 and above venous oxygen saturations. The expected range for a neonate is between 60 and 90%. However, there is not enough clinical follow-up data to tell us what it means for patients to be outside of this range, and therefore should the bedside physician take action to correct a patient outside this normal range. One of the benefits of this study was to identify a cohort of patients that had a wide range of SctO 2 measurements that will be able to be followed up in developmental clinic in the future.
Earlier studies looking at cerebral blood flow in ECMO patients, particularly animal studies, had shown that there was no decrease in cerebral blood flow during cannulation. However, patients enrolled in this study showed that there was a transient drop in cerebral oxygenation during and postcannulation, particularly if there was a delay between cannulation and the start of bypass flow. The other unexpected finding was the effectiveness of the cerebral oximeter as a useful tool during cardiopulmonary arrest. During this state, there is a loss of pulsatile flow and a stagnation of the blood. Therefore, the measurements of pulse oximetry, cephalad, jugular bulb oximetry and arterial blood gas measurements are all compromised. Because cerebral oximetry relies on direct measurement of tissue saturation, pulsatile flow is not necessary for continued measurement. It was found in multiple study patients that the SctO 2 measurements could be followed to determine the effectiveness of chest compressions during CPR.
Conclusion
The use of cerebral oximetry to measure SctO 2 is a useful, noninvasive, rapid way to measure cerebral oxygenation. This monitor is now being recognized as a useful bedside tool for management of critically ill neonates. In the future, further studies will be needed to assess long-term outcomes for patients with low cerebral saturations.
